These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22105930)

  • 1. Discovery of a potent and highly β1 specific proteasome inhibitor from a focused library of urea-containing peptide vinyl sulfones and peptide epoxyketones.
    van der Linden WA; Willems LI; Shabaneh TB; Li N; Ruben M; Florea BI; van der Marel GA; Kaiser M; Kisselev AF; Overkleeft HS
    Org Biomol Chem; 2012 Jan; 10(1):181-94. PubMed ID: 22105930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SylC catalyzes ureido-bond formation during biosynthesis of the proteasome inhibitor syringolin A.
    Imker HJ; Walsh CT; Wuest WM
    J Am Chem Soc; 2009 Dec; 131(51):18263-5. PubMed ID: 19968303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptido sulfonyl fluorides as new powerful proteasome inhibitors.
    Brouwer AJ; Jonker A; Werkhoven P; Kuo E; Li N; Gallastegui N; Kemmink J; Florea BI; Groll M; Overkleeft HS; Liskamp RM
    J Med Chem; 2012 Dec; 55(24):10995-1003. PubMed ID: 23170994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel peptidomimetics containing a vinyl sulfone moiety as proteasome inhibitors.
    Ettari R; Bonaccorso C; Micale N; Heindl C; Schirmeister T; Calabrò ML; Grasso S; Zappalà M
    ChemMedChem; 2011 Jul; 6(7):1228-37. PubMed ID: 21506279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a new class of proteasome inhibitors with an epoxyketone warhead: Rational hybridization of non-peptidic belactosin derivatives and peptide epoxyketones.
    Kawamura S; Unno Y; Asai A; Arisawa M; Shuto S
    Bioorg Med Chem; 2014 Jun; 22(12):3091-5. PubMed ID: 24814885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits.
    Kessler BM; Tortorella D; Altun M; Kisselev AF; Fiebiger E; Hekking BG; Ploegh HL; Overkleeft HS
    Chem Biol; 2001 Sep; 8(9):913-29. PubMed ID: 11564559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition.
    Clerc J; Groll M; Illich DJ; Bachmann AS; Huber R; Schellenberg B; Dudler R; Kaiser M
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6507-12. PubMed ID: 19359491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate-guided optimization of the syringolins yields potent proteasome inhibitors with activity against leukemia cell lines.
    Totaro KA; Barthelme D; Simpson PT; Sauer RT; Sello JK
    Bioorg Med Chem; 2015 Sep; 23(18):6218-22. PubMed ID: 26296913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudopeptides with aldehyde or vinylsulfone warheads: Synthesis and antiproteasomal activity.
    Jorda R; Molitorová V; Pilařová E; Vojáčková V; Řezníčková E; Svobodová K; Pauk K; Imramovský A; Kryštof V
    Bioorg Chem; 2021 Oct; 115():105228. PubMed ID: 34371374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors.
    Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L
    J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syringolin B-inspired proteasome inhibitor analogue TIR-203 exhibits enhanced biological activity in multiple myeloma and neuroblastoma.
    Opoku-Ansah J; Ibarra-Rivera TR; Pirrung MC; Bachmann AS
    Pharm Biol; 2012 Jan; 50(1):25-9. PubMed ID: 22196580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugar amino acid based peptide epoxyketones as potential proteasome inhibitors.
    Risseeuw MD; Florea BI; van der Marel GA; Overkleeft HS; Overhand M
    Bioorg Chem; 2010 Oct; 38(5):202-9. PubMed ID: 20493511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nature of pharmacophore influences active site specificity of proteasome inhibitors.
    Screen M; Britton M; Downey SL; Verdoes M; Voges MJ; Blom AE; Geurink PP; Risseeuw MD; Florea BI; van der Linden WA; Pletnev AA; Overkleeft HS; Kisselev AF
    J Biol Chem; 2010 Dec; 285(51):40125-34. PubMed ID: 20937826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of proteasome subunit selectivity of syringolins.
    Tatsumi K; Kitahata S; Komatani Y; Katsuyama A; Yakushiji F; Ichikawa S
    Bioorg Med Chem; 2024 May; 106():117733. PubMed ID: 38704960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urea-containing peptide boronic acids as potent proteasome inhibitors.
    Han LQ; Yuan X; Wu XY; Li RD; Xu B; Cheng Q; Liu ZM; Zhou TY; An HY; Wang X; Cheng TM; Ge ZM; Cui JR; Li RT
    Eur J Med Chem; 2017 Jan; 125():925-939. PubMed ID: 27769033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixing of peptides and electrophilic traps gives rise to potent, broad-spectrum proteasome inhibitors.
    Verdoes M; Florea BI; van der Linden WA; Renou D; van den Nieuwendijk AM; van der Marel GA; Overkleeft HS
    Org Biomol Chem; 2007 May; 5(9):1416-26. PubMed ID: 17464411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Analyses of Substrate Preferences of 20S Proteasomes Using Peptidic Epoxyketone Inhibitors.
    Huber EM; de Bruin G; Heinemeyer W; Paniagua Soriano G; Overkleeft HS; Groll M
    J Am Chem Soc; 2015 Jun; 137(24):7835-42. PubMed ID: 26020686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S beta5-subunit.
    Blackburn C; Gigstad KM; Hales P; Garcia K; Jones M; Bruzzese FJ; Barrett C; Liu JX; Soucy TA; Sappal DS; Bump N; Olhava EJ; Fleming P; Dick LR; Tsu C; Sintchak MD; Blank JL
    Biochem J; 2010 Sep; 430(3):461-76. PubMed ID: 20632995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of peptide epoxyketones as selective immunoproteasome inhibitors.
    Li X; Hong D; Zhang M; Xu L; Zhou Y; Li J; Liu T
    Eur J Med Chem; 2021 Oct; 221():113556. PubMed ID: 34087498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides.
    Brouwer AJ; Herrero Álvarez N; Ciaffoni A; van de Langemheen H; Liskamp RM
    Bioorg Med Chem; 2016 Aug; 24(16):3429-35. PubMed ID: 27316540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.